These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14995965)

  • 1. Skin concentrations of thromboxane synthetase inhibitor after topical application with bioelastic membrane.
    Wang NZ; Urry DW; Swaim SF; Gillette RL; Hoffman CE; Hinkle SH; Coolman SL; Luan CX; Xu J; Kemppainen BW
    J Vet Pharmacol Ther; 2004 Feb; 27(1):37-43. PubMed ID: 14995965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioelastic membranes for topical application of a thromboxane synthetase inhibitor for protection of skin from pressure injury: a preliminary study.
    Kemppainen BW; Urry DW; Swaim SF; Sartin EA; Gillette RL; Hinkle SH; Coolman SL; Luan CX; Xu J
    Wound Repair Regen; 2004; 12(4):453-60. PubMed ID: 15260811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro skin penetration of dazmegrel delivered with a bioelastic matrix.
    Kemppainen BW; Urry DW; Luan CX; Xu J; Swaim SF; Goel S
    Int J Pharm; 2004 Mar; 271(1-2):301-3. PubMed ID: 15129998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the thromboxane synthetase inhibitor Dazmegrel (UK-38,485) on wound healing, dermal ink perfusion and skin blood flow measurements in deep partial thickness burns.
    Wang SL; Silberstein EB; Lukes S; Robb E; Zou WZ; Bruno L; Heyd TJ; Waymack JP; Alexander JW
    Burns Incl Therm Inj; 1986 Jun; 12(5):312-7. PubMed ID: 3730910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the thromboxane synthetase inhibitor dazmegrel (UK 38,485) on skin blood flow in deep partial thickness burns].
    Wang SL
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1989 Sep; 5(3):206-9, 239-40. PubMed ID: 2514031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of UK-38485 (dazmegrel), a specific inhibitor of thromboxane A2 synthetase.
    Rebec MV; Skrinska VA
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):207-12. PubMed ID: 2622975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thromboxane synthetase accentuates hemodynamic instability and burn edema in the anesthetized sheep model.
    LaLonde C; Demling RH
    Surgery; 1989 May; 105(5):638-44. PubMed ID: 2705099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
    Norris LA; Devitt M; Bonnar J
    Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition.
    Edstrom LE; Balkovich M; Slotman GJ
    Ann Plast Surg; 1988 Feb; 20(2):106-11. PubMed ID: 3281544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
    Guth BD; Müller TH
    Basic Res Cardiol; 1997 Jun; 92(3):181-90. PubMed ID: 9226103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor.
    Belch JJ; Saniabadi AR; McLaughlin K; Forbes CD
    Lipids; 1987 Mar; 22(3):159-62. PubMed ID: 3573995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatography with fluorescence detection of dazmegrel, a specific thromboxane A2 synthetase inhibitor.
    Rebec MV; Skrinska VA
    J Chromatogr; 1988 Nov; 432():375-80. PubMed ID: 3220909
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboxane A2 and development of genetic hypertension in the Lyon rat strain.
    Geoffroy J; Benzoni D; Vincent M; Sassard J
    Hypertension; 1990 Dec; 16(6):655-61. PubMed ID: 2147173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1985; 7(2):327-34. PubMed ID: 2581088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers.
    Uematsu T; Kosuge K; Umemura K; Nakano M; Terakawa M; Nakashima M
    J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A thromboxane A2 synthetase inhibitor as an anticoagulant for left ventricular assist devices.
    Takahama T; Kanai F; Onishi K
    ASAIO J; 1997; 43(5):M452-6. PubMed ID: 9360083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
    Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
    Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of a thromboxane synthetase inhibitor and continuous arteriovenous hemofiltration in rat endotoxic shock.
    Heidemann SM; Sarnaik AP
    Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):473-8. PubMed ID: 9223660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal group B streptococcal sepsis: effects of late treatment with dazmegrel.
    Truog WE; Gibson RL; Juul SE; Henderson WR; Redding GJ
    Pediatr Res; 1988 Apr; 23(4):352-6. PubMed ID: 3287320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.